Alethia Biotherapeutics Submits a Clinical Trial Application (CTA) for a Phase I Study with AB-16B5, an Inhibitor of EMT in Patients with Advanced Cancers
XL-protein and GENERIUM sign broad therapeutic license
Archive by year:
21 March 2012
The visit of President Medvedev
During his business trip to Vladimir region, Dmitry Medvedev visited the International Biotechnology Center (IBC) “Generium” (LLC IBC Generium).
© 2015, The International Biotechnology Center (IBC) “Generium”